Sweet综合征伴抗γ干扰素自身抗体阳性的播散性非结核分枝杆菌病1例

doi:10.35541/cjd.20210791

中华皮肤科杂志 ›› 2022, e20210791.doi: 10.35541/cjd.20210791

Sweet综合征伴抗γ干扰素自身抗体阳性的播散性非结核分枝杆菌病1例

韦立莉^1，2 曹存巍^1，2 林有坤¹ 郑文军¹ 刘栋华¹

¹广西医科大学第一附属医院皮肤性病科，南宁 530021；²广西壮族自治区卫生健康委员会真菌研究与真菌病防治重点实验室，南宁 530021

收稿日期:2021-10-28 修回日期:2022-04-29 发布日期:2022-09-05
通讯作者: 曹存巍 E-mail:caocunwei@yeah.net
基金资助:
国家自然科学基金（82173433）；广西医科大学第一附属医院省部级重点实验室培育项目（YYZS2020006）

A case of Sweet syndrome complicated by anti-interferon-γ autoantibody-associated nontuberculous mycobacterial disease

Wei Lili^1,2, Cao Cunwei^1,2, Lin Youkun¹, Zheng Wenjun¹, Liu Donghua¹

¹Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China; ²Guangxi Health Commission Key Lab of Fungi and Mycosis Research and Prevention, Nanning 530021, China

Received:2021-10-28 Revised:2022-04-29 Published:2022-09-05
Contact: Cao Cunwei E-mail:caocunwei@yeah.net
Supported by:
National Natural Science Foundation of China （82173433）; The First Affiliated Hospital of Guangxi Medical University Provincial and Ministerial Key Laboratory Cultivation Project （YYZS2020006）

摘要/Abstract

摘要： 患者女，50岁，因发热、颈部肿物4个月、全身皮疹2个月于2021年6月15日入院。4个月前无明显诱因出现发热，最高体温38.5℃，伴畏寒、头痛，颈部淋巴结肿大、疼痛，外院予抗感染、止痛等治疗无好转……

韦立莉曹存巍林有坤郑文军刘栋华. Sweet综合征伴抗γ干扰素自身抗体阳性的播散性非结核分枝杆菌病1例[J]. 中华皮肤科杂志, 2022,e20210791. doi:10.35541/cjd.20210791

参考文献 8

［1］	付玉姣, 郭静, 史娜娜, 等. 抗γ干扰素自身抗体阳性伴Sweet综合征的马尔尼菲篮状菌病九例临床分析［J］. 中华皮肤科杂志, 2020,53（2）: 109⁃112. doi: 10.35541/cjd.20190746.
［2］	Nofal A, Abdelmaksoud A, Amer H, et al. Sweet′s syndrome: diagnostic criteria revisited［J］. J Dtsch Dermatol Ges, 2017,15（11）:1081⁃1088. doi: 10.1111/ddg.13350.
［3］	Chaowattanapanit S, Choonhakarn C, Chetchotisakd P, et al. Clinical features and outcomes of Sweet′s syndrome associated with non⁃tuberculous mycobacterial infection and other associated diseases［J］. J Dermatol, 2016,43（5）:532⁃536. doi: 10.1111/1346⁃8138.13167.
［4］	Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult⁃onset immunodeficiency in Thailand and Taiwan［J］. N Engl J Med, 2012,367（8）:725⁃734. doi: 10.1056/NEJMoa1111160.
［5］	Dorman SE, Holland SM. Interferon⁃gamma and interleukin⁃12 pathway defects and human disease［J］. Cytokine Growth Factor Rev, 2000,11（4）:321⁃333. doi: 10.1016/s1359⁃6101（00）00010⁃1.
［6］	Jutivorakool K, Sittiwattanawong P, Kantikosum K, et al. Skin manifestations in patients with adult⁃onset immunodeficiency due to anti⁃interferon⁃gamma autoantibody: a relationship with systemic infections［J］. Acta Derm Venereol, 2018,98（8）:742⁃747. doi: 10.2340/00015555⁃2959.
［7］	Kampitak T, Suwanpimolkul G, Browne S, et al. Anti⁃interferon⁃γ autoantibody and opportunistic infections: case series and review of the literature［J］. Infection, 2011,39（1）:65⁃71. doi: 10.1007/s15010⁃010⁃0067⁃3.
［8］	Xu H, Liu D, He X, et al. Sweet′s syndrome associated with Talaromyces marneffei and Mycobacterium abscessus infection due to anti⁃interferon⁃gamma autoantibodies［J］. Indian J Dermatol, 2018,63（5）:428⁃430. doi: 10.4103/ijd.IJD_362_17.

Sweet综合征伴抗γ干扰素自身抗体阳性的播散性非结核分枝杆菌病1例

A case of Sweet syndrome complicated by anti-interferon-γ autoantibody-associated nontuberculous mycobacterial disease

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 8

相关文章 0

Metrics

本文评价

推荐阅读 10